Home » J&J-GUIDANT MERGER TO SHAKE UP STENT MARKET
J&J-GUIDANT MERGER TO SHAKE UP STENT MARKET
Healthcare giant Johnson & Johnson recently agreed to buy heart-device maker
Guidant for $21.5 billion, ending a month of uncertainty about the deal and
creating a new competitive landscape for Boston Scientific, the largest life-sciences
company in Massachusetts.
Boston
Globe
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May